Inclusive of all taxes
RIZATRAX 10 Tablet by Dr Precision is a specialized prescription medication formulated for the acute treatment of migraine attacks, with or without aura. Containing Rizatriptan Benzoate, a selective serotonin (5-HT1B/1D) receptor agonist, RIZATRAX 10 acts by constricting dilated intracranial blood vessels and inhibiting pro-inflammatory neuropeptides that cause migraine symptoms such as severe headaches, nausea, and sensitivity to light and sound. Designed for fast relief, it typically begins acting within 30 minutes to 2 hours after administration, making it a preferred choice for patients requiring prompt migraine symptom control. The tablet is easy to swallow and can be taken with or without food. It offers flexible dosing with a recommended single dose of 10 mg, and the option for a second dose after two hours if the migraine recurs, without exceeding the prescribed daily limit. Manufactured under Dr Precision's GMP-compliant protocols, RIZATRAX 10 ensures high-quality, precise formulation and stability. This product is ideal for healthcare providers managing patients with debilitating migraines who need an effective, fast-acting treatment to restore daily functionality and improve quality of life. RIZATRAX 10 is not indicated for migraine prevention or other headache types and should be used cautiously in patients with cardiovascular risks or specific medication histories. The product is supplied in tamper-proof packaging, assuring safety and efficacy until consumption.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Rizatriptan Benzoate |
| Therapeutic Use | Acute treatment of migraine attacks with or without aura |
| Mechanism of Action | Selective serotonin (5-HT1B/1D) receptor agonist that constricts intracranial blood vessels |
| Onset of Action | Typically within 30 minutes to 2 hours |
| Dosage Form | Oral tablet, easy-to-swallow |
| Recommended Dose | 10 mg once, second dose possible after 2 hours if needed |
| Manufacturer | Dr Precision, GMP-certified |
| Packaging | Tamper-proof for safety and potency |
| Adjunct Use | Not for migraine prevention or cluster headaches |
| Side Effects | Mild dizziness, dry mouth, fatigue, tingling, drowsiness, chest discomfort |
| Attributes | Description |
|---|---|
| Drug Class | Triptan (Selective serotonin receptor agonist) |
| Indications | Acute migraine treatment with or without aura |
| Contraindications | Ischemic heart disease, uncontrolled hypertension, stroke, peripheral vascular disease, recent use of ergotamine or other triptans |
| Administration Route | Oral |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Packaging Size | Supply varies, packaged in tamper-proof containers |
| Regulatory Compliance | Manufactured under GMP and international pharmaceutical standards |
| Drug Interactions | Potential interactions with MAO inhibitors, propranolol, certain antidepressants |
| Pregnancy Category | Use only under medical supervision |
| Patient Population | Adults experiencing acute migraine attacks with or without aura |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
No, RIZATRAX 10 should not exceed the maximum prescribed daily dose which typically allows only two doses within 24 hours, with a minimum gap of 2 hours between doses.
RIZATRAX 10 is contraindicated in patients with ischemic heart disease, uncontrolled hypertension, stroke history, or peripheral vascular disease due to risk of coronary vasospasm.
RIZATRAX 10 can be taken with or without food; however, food may slightly delay the onset of relief but does not affect overall effectiveness.
Healthcare providers should monitor for cardiovascular side effects, possible drug interactions, and assess patient history for contraindications such as recent use of ergotamine or other triptans.
No, RIZATRAX 10 is indicated only for the acute treatment of migraine attacks with or without aura and is not effective for migraine prevention or cluster headaches.
RIZATRAX 10 reduces accompanying symptoms such as nausea, photophobia (light sensitivity), and phonophobia (sound sensitivity) by targeting serotonin receptors and reducing neuropeptide-induced inflammation.
Yes, caution is advised for patients with liver or kidney impairment, and healthcare professionals may adjust dosage accordingly.
Country Of Origin: India
RIZATRAX 10 Tablet contains Rizatriptan Benzoate, a fast-acting medication used for the acute treatment of migraine attacks with or without aura. It works by narrowing blood vessels around the brain and reducing migraine-related symptoms such as headache, nausea, and sensitivity to light and sound, offering quick relief when taken at the onset of a migraine.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
RIZATRAX 10 Tablet is a prescription medication that contains Rizatriptan Benzoate, a selective serotonin (5-HT1B/1D) receptor agonist used primarily for the acute treatment of migraine attacks, with or without aura. This medication belongs to the class of drugs known as triptans, which are specifically formulated to relieve migraines by acting directly on the serotonin receptors in the brain to reverse the dilation of blood vessels and interrupt the cascade of events believed to cause migraine symptoms.
Rizatriptan, the active pharmaceutical ingredient in RIZATRAX 10, exerts its therapeutic effect by stimulating serotonin receptors found on intracranial blood vessels. During a migraine attack, these vessels dilate, leading to pain and inflammation. Rizatriptan works by constricting these vessels and inhibiting the release of pro-inflammatory neuropeptides. As a result, it alleviates not only the intense headache but also associated symptoms like nausea, photophobia (sensitivity to light), and phonophobia (sensitivity to sound). This makes RIZATRAX 10 a comprehensive and highly effective solution for treating active migraine episodes.
RIZATRAX 10 is not intended for the prevention of migraines or for use in treating other types of headaches, such as cluster headaches. It is most effective when taken at the first sign of migraine symptoms, but can still provide relief if taken later during the attack. Its fast onset of action—typically within 30 minutes to 2 hours—makes it a preferred option among patients and healthcare professionals for prompt symptom control.
The recommended dose of RIZATRAX 10 is generally 10 mg once, with a second dose possible after at least two hours if the migraine returns, but not exceeding the maximum prescribed daily limit. It can be taken with or without food, although food may slightly delay the onset of relief. For optimal results, it is advised to take the tablet as soon as the migraine begins to intensify.
RIZATRAX 10 is especially useful for patients whose migraines interfere with daily function, productivity, or quality of life. By reducing both the severity and duration of migraines, it helps patients regain control and resume normal activities more quickly. It is available in an easy-to-swallow tablet form, which improves patient compliance and convenience.
Although RIZATRAX 10 is generally well tolerated, it may cause side effects in some individuals. These can include dizziness, dry mouth, fatigue, tingling sensations, drowsiness, or chest discomfort. These side effects are typically mild and short-lived. However, patients are advised to seek immediate medical attention if they experience symptoms suggestive of a heart condition, such as shortness of breath, chest pain, or an irregular heartbeat, as triptans can occasionally cause coronary vasospasm in susceptible individuals.
RIZATRAX 10 should not be used by individuals with a history of ischemic heart disease, uncontrolled hypertension, stroke, or peripheral vascular disease. It is also contraindicated in patients who have taken ergotamine-containing medications or other triptans within the last 24 hours. Caution is warranted in individuals with liver or kidney impairment, and dosage adjustments may be necessary in such populations.
Women who are pregnant or breastfeeding should only use RIZATRAX 10 under strict medical supervision. Drug interactions may occur with monoamine oxidase inhibitors (MAOIs), propranolol, and certain antidepressants, so patients must inform their healthcare provider of all medications they are taking.
RIZATRAX 10 is manufactured in certified pharmaceutical facilities adhering to GMP and international regulatory standards. Each tablet undergoes stringent quality control to ensure purity, stability, and consistent clinical efficacy. The product is supplied in tamper-proof packaging that safeguards the integrity and potency of the medication until it is consumed.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze